1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Israel Pharmaceuticals and Healthcare Report Q2 2016

Israel Pharmaceuticals and Healthcare Report Q2 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 106 pages

Includes 3 FREE quarterly updates

BMI View: Our growth outlook for Israel's pharmaceutical sector is underpinned by the governmentpackage to systematically bolster the public health system through targeted investment in health resourcesand infrastructure. Concerted efforts to grow the interface between private and public medicine and animproving intellectual property picture will ensure commercial opportunities remain for pharmaceuticalcompanies.

Headline Expenditure Projections

- Pharmaceuticals: ILS7.82bn (USD2.01bn) in 2015 to ILS8.16bn (USD2.11bn) in 2016; +4.3% in localcurrency terms and +4.6% in US dollar terms. Forecast upgraded from Q116.

- Healthcare: ILS85.80bn (USD22.09bn) in 2015 to ILS91.29bn (USD23.59bn) in 2016; +6.4% in localcurrency terms and +6.8% in US dollar terms. Forecast upgraded from Q116.

Table Of Contents

Israel Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Israel 2014-2020) 7
SWOT Analysis 9
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Israel 2012-2020) 12
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Israel 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Israel 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Israel 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Israel 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Israel 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Israel 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Israel 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Israel 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Israel 2014-2020) 30
Industry Risk/Reward Index 31
Middle East and Africa Risk/Reward Index - Q2 2016 31
Israel Risk/Reward Index 38
Rewards 38
Risks 38
Regulatory Review 40
Intellectual Property Issues 42
Pricing Regime 45
Table: Price Build-Up In The Israeli Pharmaceutical Market 46
Reimbursement Regime 46
Market Overview 51
Healthcare Sector 51
Table: Healthcare Resources (Israel 2010-2015) 57
Table: Healthcare Personnel (Israel 2010-2015) 57
Table: Healthcare Activity (Israel 2010-2015) 58
Research and Development 58
Table: Israel's RandD Legislation - Conditions For OCS Funding 60
Clinical Trials 61
Epidemiology 65
Competitive Landscape 68
Research-Based Industry 68
Table: Multinational Pharmaceutical Company Activity 71
Pharmaceutical Distribution 72
Pharmaceutical Retail Sector 72
Company Profile 73
Dexcel Pharma 73
Neopharm Group 76
Perrigo (Agis Industries) 79
Taro Pharmaceutical Industries 83
Teva Pharmaceutical Industries 87
Demographic Forecast 95
Table: Population Headline Indicators (Israel 1990-2025) 96
Table: Key Population Ratios (Israel 1990-2025) 97
Table: Urban/Rural Population and Life Expectancy (Israel 1990-2025) 97
Table: Population By Age Group (Israel 1990-2025) 98
Table: Population By Age Group % (Israel 1990-2025) 99
Glossary 100
Methodology 102
Pharmaceutical Expenditure Forecast Model 102
Healthcare Expenditure Forecast Model 102
Notes On Methodology 103
Risk/Reward Index Methodology 104
Index Overview 105
Table: Pharmaceutical Risk/Reward Index Indicators 105
Indicator Weightings 106

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Poultry Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Poultry Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • September 2016
  • by Transparency Market Research

This report on the poultry pharmaceuticals market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.